Monitor for additional insider selling in the next quarter; current activity is routine and likely related to pre-scheduled 10b5-1 plans or portfolio diversification, not a signal of distress.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 11 $108.09entry
- T+1 · 8mo ago −1.43%α +0.05% · $106.54
- T+5 · 8mo ago +2.55%α +4.74% · $110.85
- T+20 · 7mo ago +4.27%α +3.75% · $112.71
- T+60 · 6mo ago −15.22%α −26.74% · $91.64
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple LEMAITRE VASCULAR (LMAT) insiders conducted transactions over a 7-day period, including open-market sales by the President and Senior VP of Operations totaling $641,398, alongside non-cash derivative exercises and tax withholdings. The core economic activity involves meaningful insider selling, though still under 0.1% of the company's $2.4B market cap.
Key Financial Metrics
Key Facts
- President David B Roberts sold 3,311.68 shares at $107.6752, totaling $356,586 in open-market sale.
- SVP Operations Trent G Kamke sold 2,625 shares at $108.5, totaling $284,812 in open-market sale.
- Kamke also exercised 5,250 derivative shares (two tranches of 2,625), with one costing $35.48/share ($93,135 total cash outlay), and the other at $0 (likely previously vested).
- CFO Dorian Paul exercised 4 derivative shares (two transactions of 2 shares each) at $0 and surrendered 96 shares for tax withholding totaling $10,483.
- All transactions occurred between 2026-03-10 and 2026-03-11.
- Total open-market sale proceeds: $641,398; total non-cash transactions: $103,618 (exercises and tax).
Financial Impact
Total open-market selling of $641,398 represents 0.027% of LMAT's $2.4B market cap, well below the 0.1% threshold for materiality.
Risk Factors
- Perception risk if media or retail investors misinterpret the selling as negative despite low magnitude.
- Future clusters with higher dollar volume or broader participation could signal real concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-LMAT-1773434612772 |
Track record
14 reports on LMAT
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.08% at T+20 after the May 7, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bearish 6/10 Entry $83.49 to $77.65 Now $77.01 +7.76% ▲ +6.99% +10.29% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $80.60 to $79.02 Now $77.01 −4.45% ▼ −1.96% −1.37% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $80.82 to $84.45 Now $77.01 −4.71% ▲ +4.49% +4.40% vs SPY
- Aug 27, 202611w ago Press Release Neutral 2/10 Entry $80.45 to $80.67 Now $77.01 −4.28% ▲ +0.27% +0.16% vs SPY
- Jul 14, 202617w ago Press Release Neutral 1/10 Entry $99.79 Now $77.01 −22.83% No price data
- May 7, 202627w ago Insider Cluster Bearish 4/10 Entry $107.91 to $98.17 Now $77.01 +28.63% ▲ +9.03% +10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 2/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 3/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 5, 202627w ago 8-K Bullish 7/10 Entry $110.22 to $97.22 Now $77.01 −30.13% ▼ −11.79% −12.93% vs SPY
- Apr 14, 202630w ago DEFA14A Neutral 3/10 Entry $117.39 to $111.90 Now $77.01 −34.40% ▼ −4.68% −6.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers